Investments
387Portfolio Exits
95Funds
7About Great Oaks Venture Capital
Great Oaks Venture Capital is a seed-stage investment firm committed to identifying, financing and developing early-stage growth businesses. Based in New York City, GOVC was founded by Andrew Boszhardt, a financial entrepreneur with approximately 35 years of capital market experience. GOVC's typical investment size ranges from $50K to $500K.

Want to inform investors similar to Great Oaks Venture Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Great Oaks Venture Capital
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Great Oaks Venture Capital in 3 Expert Collections, including Store tech (In-store retail tech).
Store tech (In-store retail tech)
55 items
Startups aiming work with retailers to improve brick-and-mortar retail operations.
Education Technology (Edtech)
58 items
CB Insights Consumer Smart Money Investors - 2020
25 items
Track the world's top-performing VC investors in consumer. Firms are presented in alphabetical order.
Research containing Great Oaks Venture Capital
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Great Oaks Venture Capital in 1 CB Insights research brief, most recently on Jun 11, 2020.

Jun 11, 2020
Market Map: 50+ Startups Reshaping Auto CommerceLatest Great Oaks Venture Capital News
Apr 24, 2023
Cure – a functional hydration brand – announced $5.6 million in Series A funding and retail expansion to 15,000 stores nationwide, further cementing the brand as a key player in the $10 billion functional drink mix market. This funding round was led by Lerer Hippeau with additional participation from new and existing investors including Valedor Partners, Simple Food Ventures, Great Oaks Venture Capital, Joyance Partners, Silas Capital, Kim Clijsters, and others. Cure will utilize the funding to accelerate retail expansion, grow its leadership team, enhance customer awareness, and develop new products. Since launching in 2019, Cure has grown an average of 230% every year and expanded its retail footprint to include new retail partners like Sprouts, Albertsons, Kroger, Stop & Shop, Wegmans and HEB, joining existing accounts including CVS and Walgreens. In the past 12 weeks, Cure had grown 316% in the Natural channel compared to the overall category growing at 19.5%, making Cure the fastest-growing natural hydration brand, according to SPINS. Known as the only female-founded electrolyte brand – which is also majority women operated and has an all-female medical and nutritional advisory board – Cure is also the recipient of a 2022 Fitness Award from Women’s Health magazine, and counts Gwyneth Paltrow, Ashley Graham, Brooklyn Decker, and Miranda Kerr among its many celebrity fans. Cure – which is on a mission to empower others to live better and healthier lives – is uniquely positioned to capture a major portion of the $10 billion functional drink mix market by creating science-backed wellness products with clean, effective ingredients at affordable prices. And its plant-based electrolyte powders are based on the World Health Organization’s ORS formula, but unlike other ORS formulas, its ingredients are non-GMO, sustainably sourced, and have no added sugar or erythritol. Plus Cure also launched new electrolyte flavors earlier this year including Lemonade and Strawberry Kiwi, and introduced a new bulk jar format. Cure is continuing to add industry veterans to its leadership team, announcing recently that the company has brought on Laura Kendrick as their Chief Marketing Officer, formerly at Highline Wellness and SmartyPants Vitamins, and Stacey Gillespie as their VP of Innovation, formerly Ora Organic and Gaia Herbs. Cure is backed by a medical advisory board that includes Dr. Roshini Raj, Dr. Dana Cohen, and Brooke Alpert and is FSA/HSA Eligible. And in just over 4 years, Cure has expanded to over 15,000 retail stores nationwide including CVS, Walgreens, Albertsons, and Sprouts. KEY QUOTES: “In the past four years, Cure has seen explosive growth as consumers look for better-for-you functional beverages that really work and aren’t full of added sugar. Cure is on a mission to create healthy and effective products that provide the ultimate foundation for health and well-being.” Lauren Picasso, CEO and founder at Cure Hydration “We are excited to partner with Cure, an omnichannel hydration company we believe is poised for breakout growth in the $10 billion functional drink mix market. After only launching in 2019, the brand has quickly gained traction online and in over 15,000 doors. We believe Cure’s high performance is attributable to its outstanding team, especially CEO and Founder Lauren Picasso whose drive, magnetism and experience bode well for Cure’s future success. We can’t wait to see what Cure accomplishes in the coming years.” Valedor Partners’ Barbara Palmquist “We continue to invest in Cure because the team has proved that they can scale beyond direct-to-consumer to become an omnichannel brand with a national footprint. We are excited to see Cure’s continued retail distribution and disruption of the hydration category.” Caitlin Strandberg, Partner at Lerer Hippeau Trending on Pulse 2.0
Great Oaks Venture Capital Investments
387 Investments
Great Oaks Venture Capital has made 387 investments. Their latest investment was in Triumph Labs as part of their Series A on May 5, 2023.

Great Oaks Venture Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/10/2023 | Series A | Triumph Labs | $10.2M | Yes | 1 | |
4/17/2023 | Series A | Cure Hydration | $5.6M | Yes | Great Oaks Venture Capital, Kim Clijsters, Lerer Hippeau, Silas Capital, Simple Food Ventures, Social Starts, Undisclosed Investors, and Valedor Partners | 2 |
2/13/2023 | Seed VC - III | Twentyeight Health | $8.3M | Yes | Acumen, Aglae Ventures, Andrey Ostrovsky, California Health Care Foundation, Elina Onitskansky, Gingerbread Capital, Gratitude Railroad, Great Oaks Venture Capital, Impact Engine, Penn Medicine, Rhia Ventures, Seae Ventures, Stardust Equity, SteelSky Ventures, Third Prime Capital, and Town Hall Ventures | 1 |
1/20/2023 | Seed VC | |||||
1/6/2023 | Seed VC |
Date | 5/10/2023 | 4/17/2023 | 2/13/2023 | 1/20/2023 | 1/6/2023 |
---|---|---|---|---|---|
Round | Series A | Series A | Seed VC - III | Seed VC | Seed VC |
Company | Triumph Labs | Cure Hydration | Twentyeight Health | ||
Amount | $10.2M | $5.6M | $8.3M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Great Oaks Venture Capital, Kim Clijsters, Lerer Hippeau, Silas Capital, Simple Food Ventures, Social Starts, Undisclosed Investors, and Valedor Partners | Acumen, Aglae Ventures, Andrey Ostrovsky, California Health Care Foundation, Elina Onitskansky, Gingerbread Capital, Gratitude Railroad, Great Oaks Venture Capital, Impact Engine, Penn Medicine, Rhia Ventures, Seae Ventures, Stardust Equity, SteelSky Ventures, Third Prime Capital, and Town Hall Ventures | |||
Sources | 1 | 2 | 1 |
Great Oaks Venture Capital Portfolio Exits
95 Portfolio Exits
Great Oaks Venture Capital has 95 portfolio exits. Their latest portfolio exit was Plastiq on May 24, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/24/2023 | Asset Sale | 5 | |||
5/17/2023 | Acquired - II | 1 | |||
2/23/2023 | Acq - Pending | 2 | |||
Date | 5/24/2023 | 5/17/2023 | 2/23/2023 | ||
---|---|---|---|---|---|
Exit | Asset Sale | Acquired - II | Acq - Pending | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 5 | 1 | 2 |
Great Oaks Venture Capital Fund History
7 Fund Histories
Great Oaks Venture Capital has 7 funds, including Springboard SPV IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/10/2019 | Springboard SPV IV | $2.07M | 1 | ||
8/5/2013 | Great Oaks Venture Fund | ||||
4/15/2009 | Great Oaks Strategic Investment Partners | ||||
2/2/2009 | Great Oaks Opportunistic Distressed Securities Fund | ||||
11/1/2007 | Great Oaks Strategic Investment Partners II |
Closing Date | 9/10/2019 | 8/5/2013 | 4/15/2009 | 2/2/2009 | 11/1/2007 |
---|---|---|---|---|---|
Fund | Springboard SPV IV | Great Oaks Venture Fund | Great Oaks Strategic Investment Partners | Great Oaks Opportunistic Distressed Securities Fund | Great Oaks Strategic Investment Partners II |
Fund Type | |||||
Status | |||||
Amount | $2.07M | ||||
Sources | 1 |
Great Oaks Venture Capital Team
3 Team Members
Great Oaks Venture Capital has 3 team members, including current Founder, Managing Partner, Andrew Krebs Boszhardt, Jr..
Name | Work History | Title | Status |
---|---|---|---|
Andrew Krebs Boszhardt, Jr. | Founder, Managing Partner | Current | |
Name | Andrew Krebs Boszhardt, Jr. | ||
---|---|---|---|
Work History | |||
Title | Founder, Managing Partner | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.